Home › Funds › Birchview Capital, LP › FHTX

Birchview Capital, LP position in FHTX

FOGHORN THERAPEUTICS INC · Health Care

Birchview Capital, LP reported holding 282,307 shares of FHTX (FOGHORN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.60% of its reported portfolio and ranking #39 among its reported holdings. Birchview Capital, LP has disclosed FHTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)282.31K sh
Reported value held$1.01M
Portfolio Weight0.60%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Birchview Capital, LP's FHTX position evolved

Birchview Capital, LP first disclosed a stake in FHTX in Q3 2023 at 264,843 shares (US$1.3M). The position peaked in Q3 2024 at 320,930 shares, worth US$3.0M. Across 13 filings, Birchview Capital, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 282,307 shares valued at US$1.0M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 264.84K $1.32M New
Q4 2023 320.93K $2.07M Add
Q1 2024 320.93K $2.15M Hold
Q2 2024 320.93K $1.85M Hold
Q3 2024 320.93K $2.99M Hold
Q4 2024 310.93K $1.47M Reduce
Q1 2025 310.93K $1.13M Hold
Q2 2025 310.93K $1.46M Hold
Q3 2025 281.73K $1.38M Reduce
Q4 2025 281.73K $1.52M Hold
Q1 2026 281.73K $1.35M Hold
Q2 2026 281.94K $1.38M Hold
Q3 2026 282.31K $1.01M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FHTX and 13F data

FHTX (FOGHORN THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in FHTX — the largest reported positions include Flagship Pioneering, LLC (US$61.8M), BVF INC/IL (US$28.5M), Euclidean Capital LLC (US$7.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FHTX

All FHTX fund holders →

FAQ

How long has Birchview Capital, LP held FHTX?

Birchview Capital, LP has disclosed FHTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Birchview Capital, LP's current position in FHTX?

As of Q3 2026, Birchview Capital, LP holds 282.31K shares of FHTX (FOGHORN THERAPEUTICS INC), valued at $1.01M, representing 0.60% of its reported portfolio and ranking #39.

Has Birchview Capital, LP been buying or selling FHTX?

In the latest 13F filing (Q3 2026), Birchview Capital, LP held unchanged its position in FHTX. The position peaked in Q3 2024 at 320.93K shares.

Which other funds hold FHTX?

Other major institutional holders of FHTX include Flagship Pioneering, LLC, BVF INC/IL, Euclidean Capital LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.